Kimia Biosciences Intrinsic Value
Kimia Biosciences (KIMIABL) median intrinsic value is ₹64.54 from 9 valuation models (range ₹11–₹81), vs current price ₹32.27 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read KIMIABL dividend history for the complete payout history and dividend yield track record.
KIMIABL Valuation Methods Summary — DCF, Graham Number & P/E
Kimia Biosciences intrinsic value across 9 models vs current price ₹32.27 — upside/downside and value range per method. Analyse KIMIABL promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹36.08 | ₹28.86 - ₹43.30 | +11.8% | EPS: ₹1.64, Sector P/E: 22x |
| Book Value Method | asset | ₹72.00 | ₹64.80 - ₹79.20 | +123.1% | Book Value/Share: ₹36.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹64.54 | ₹58.09 - ₹70.99 | +100.0% | Revenue/Share: ₹230.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹64.54 | ₹58.09 - ₹70.99 | +100.0% | EBITDA: ₹14.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹80.68 | ₹64.54 - ₹96.82 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹10.50 | ₹9.45 - ₹11.55 | -67.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹24.32 | ₹21.89 - ₹26.75 | -24.6% | Revenue Growth: -2.3%, Adj P/E: 14.8x |
| ROE Based Valuation | profitability | ₹64.54 | ₹58.09 - ₹70.99 | +100.0% | ROE: 44.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹36.45 | ₹32.81 - ₹40.10 | +13.0% | EPS: ₹1.64, BVPS: ₹36.00 |
KIMIABL Intrinsic Value vs Market Price — All Valuation Models
Kimia Biosciences fair value range ₹11–₹81 vs current market price ₹32.27 across 9 valuation models. For current market price and key ratios, visit KIMIABL screener.
KIMIABL Intrinsic Value Analysis — Undervalued or Overvalued?
Kimia Biosciences median intrinsic value ₹64.54, current price ₹32.27 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of KIMIABL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kimia Biosciences (KIMIABL) is ₹64.54 (median value). With the current market price of ₹32.27, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹10.50 to ₹80.68, indicating ₹10.50 - ₹80.68.
Is KIMIABL undervalued or overvalued?
Based on our multi-method analysis, Kimia Biosciences (KIMIABL) appears to be trading below calculated value by approximately 100.0%.
KIMIABL Financial Health — Key Ratios vs Industry Benchmarks
Kimia Biosciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.67 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 44.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.12x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KIMIABL Cash Flow Quality — Operating & Free Cash Flow
Kimia Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹21 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹15 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-7 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |